• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate (CAS No. 1373360-92-9): A Comprehensive Overview

B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate, identified by its CAS number 1373360-92-9, is a sophisticated carbohydrate derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique structural configuration and functional groups, exhibits a range of potential applications that span from enzymatic studies to the development of novel therapeutic agents. The detailed acetylation pattern and the presence of a propyl methyl ester moiety contribute to its distinctive chemical properties, making it a subject of intense interest among researchers.

The structural complexity of B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate arises from its glucopyranose core, which is further modified by acetyl groups at the 2, 3, and 4 positions. This triacetylated derivative not only enhances the stability of the molecule but also influences its solubility and reactivity. The propyl methyl ester group adds another layer of functionality, enabling diverse interactions with biological targets. Such modifications are strategically designed to mimic natural glycosaminoglycans (GAGs), which play crucial roles in various physiological processes.

In recent years, there has been a surge in research focused on carbohydrate-based therapeutics due to their inherent biocompatibility and specificity. B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate has emerged as a key intermediate in synthesizing complex carbohydrate mimics that can interfere with pathogenic processes. For instance, studies have demonstrated its potential in inhibiting enzymes that are involved in bacterial adhesion and inflammation. The acetylated glucosuronic acid backbone provides a scaffold that can be further functionalized to target specific disease pathways.

One of the most compelling aspects of B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate is its role in glycobiology research. Glycans are essential for cell signaling and recognition processes, and understanding their structure-function relationships is crucial for developing targeted therapies. This compound serves as a valuable tool for studying the interactions between glycans and their binding partners. For example, researchers have utilized it to probe the binding mechanisms of glycosidases and lectins, which are critical for maintaining cellular homeostasis.

The pharmaceutical industry has also shown interest in B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate due to its potential as a prodrug or a lead compound for drug development. Its ability to undergo controlled hydrolysis under physiological conditions makes it an attractive candidate for delivering bioactive molecules to specific sites within the body. Additionally, its structural features allow for modifications that can enhance pharmacokinetic properties such as bioavailability and tissue distribution.

Recent advancements in synthetic chemistry have enabled the efficient preparation of B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate, making it more accessible for research applications. Techniques such as enzymatic synthesis and chemoenzymatic approaches have been employed to achieve high yields and purity levels. These methods not only improve the scalability of production but also allow for greater customization of the molecule's structure.

The biological activity of B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate has been extensively studied in vitro and in vivo. Preclinical trials have revealed promising results in models of inflammation and infection, suggesting its therapeutic potential. Researchers are particularly interested in its ability to modulate immune responses by interacting with glycan-dependent receptors on immune cells. This could pave the way for novel immunomodulatory therapies that target specific glycan pathways.

The chemical properties of this compound also make it suitable for use as a chiral auxiliary in asymmetric synthesis. Chiral molecules are crucial in pharmaceuticals because they often exist as enantiomers with different biological activities. By incorporating B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate into synthetic routes, chemists can selectively produce enantiomerically pure compounds with enhanced efficacy and reduced side effects.

In conclusion,B-D-Glucopyranosiduronic Acid Propyl Methyl Ester, 2,3,4-Triacetate (CAS No. 1373360-92-9) is a multifaceted compound with significant potential in both academic research and pharmaceutical development. Its unique structural features and functional groups make it an invaluable tool for studying carbohydrate biology and developing novel therapeutics. As research continues to uncover new applications for this compound，its importance is likely to grow even further，contributing to advancements in medicine and biotechnology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)